Wedbush Reiterates Outperform on Adicet Bio, Maintains $30 Price Target

Wedbush analyst Robert Driscoll reiterates Adicet Bio (NASDAQ:ACET) with a Outperform and maintains $30 price target.

Wedbush analyst Robert Driscoll reiterates Adicet Bio (NASDAQ:ACET) with a Outperform and maintains $30 price target.

Total
0
Shares
Related Posts